Prim, S.A. (BME:PRM)
Spain · Delayed Price · Currency is EUR 12.95
+0.20 (1.57%)
Apr 7, 2026, 5:35 PM CET
Prim, S.A. Market Cap
Prim, S.A. has a market cap or net worth of €220.36 million as of April 7, 2026. Its market cap has increased by 29.76% in one year.
Market Cap
220.36M
Enterprise Value
213.09M
Revenue
253.56M
Ranking
n/a
PE Ratio
13.21
Stock Price
€12.95
Market Cap Chart
Since March 2, 1998, Prim, S.A.'s market cap has increased from 7.51M to 220.36M, an increase of 2,835.62%. That is a compound annual growth rate of 12.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 220.36M | -1.89% |
| Dec 31, 2025 | 224.61M | 37.21% |
| Dec 31, 2024 | 163.70M | -7.91% |
| Dec 29, 2023 | 177.76M | -3.62% |
| Dec 30, 2022 | 184.45M | -26.55% |
| Dec 30, 2021 | 251.13M | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 4.23B |
| Almirall | 2.65B |
| Pharma Mar | 1.58B |
| Faes Farma | 1.46B |
| Clínica Baviera | 767.29M |
| Atrys Health | 217.76M |
| Oryzon Genomics | 216.26M |